LNSR — LENSAR, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1320350 ·
Last close
$6.01
Market Cap
$73.81M
52W High
$6.47
52W Low
$5.06
ADV30
93,392
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 13,428,000 | 6,382,000 | 2,239,000 | 36,332,000 | 66,223,000 | 12,494,000 | 55,433,000 |
| Dec 2025 | 16,025,000 | 6,937,000 | -4,919,000 | -1,458,000 | 71,430,000 | 12,974,000 | 97,449,000 |
| Sep 2025 | 14,316,000 | 6,036,000 | -7,580,000 | -3,713,000 | 70,204,000 | 7,637,000 | 96,111,000 |
| Jun 2025 | 13,935,000 | 7,024,000 | -6,289,000 | -1,764,000 | 70,414,000 | 7,150,000 | 93,466,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-14,831,000
Investing CF
$1,284,000
Financing CF
$10,258,000
CapEx
$-106,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-2.90
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-177,575,000
Inventory
$21,520,000
Receivables
$6,672,000
ST Investments
$5,004,000
EBIT TTM
$-24,578,000
Pretax Income TTM
$-34,280,000
Interest Exp TTM
—
Analysts
2
Yahoo Snapshot (yfinance, live)
Total Revenue
$57,704,000
EBITDA
$-20,588,000
Free Cash Flow
$-22,666,876
Enterprise Value
$74,641,664
Total Cash
$13,495,000
Total Debt
$2,574,000
Shares Out
12,281,581
Trailing EPS
$-0.55
Book Value
$0.89
ROE
362.5%
ROA
-22.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 58,435,000 | -24,578,000 | -34,280,000 | 71,430,000 | 97,449,000 | — | -14,831,000 |
| Dec 2024 | 53,494,000 | -6,936,000 | -31,404,000 | 66,297,000 | 61,435,000 | — | -2,275,000 |
| Dec 2023 | 42,164,000 | -12,229,000 | -14,383,000 | 69,585,000 | 36,156,000 | — | -9,659,000 |
| Dec 2022 | 35,358,000 | -20,177,000 | -19,914,000 | 55,844,000 | 13,860,000 | — | -14,856,000 |
TTM Snapshot
Revenues TTM
$12,636,000
NetIncome TTM
$-9,043,000
OpCashFlow TTM
$0
Assets (Latest)
$66,297,000
Forward EPS
$-0.71
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| NNOX | Nano-X Imaging Ltd. | $73.08M | $1.05 | — |
| RTGN | RetinalGenix Technologies Inc. | $75.37M | $4.00 | — |
| SPAI | Safe Pro Group Inc. | $78.76M | $3.82 | — |
| OM | Outset Medical, Inc. | $82.12M | $4.43 | — |
| LUNG | Pulmonx Corp | $65.05M | $1.54 | — |
News headlines (Yahoo Finance, 1h cache)
Is it a Prudent Move to Retain ALC Stock in Your Portfolio Now?
2026-07-02 18:12 · Yahoo
How The LENSAR (LNSR) Story Is Shifting After The Failed Deal And New $10 Target
2026-06-04 20:14 · Yahoo
Lensar (LNSR) Q1 2026 Earnings Transcript
2026-06-01 17:10 · Yahoo
Lensar (LNSR) Q4 2025 Earnings Transcript
2026-06-01 17:10 · Yahoo
LENSAR Q1 Earnings Call Highlights
2026-05-08 18:20 · Yahoo
LENSAR® Reports First Quarter 2026 Results and Provides Business Update
2026-05-08 11:00 · Yahoo
LENSAR® to Report First Quarter 2026 Results on May 8, 2026
2026-04-30 11:00 · Yahoo
How The Failed Alcon Deal Is Reframing The LENSAR (LNSR) Story And $10 Upside Potential
2026-04-21 05:03 · Yahoo
Cedar Grove Capital Management’s Views on LENSAR (LNSR)
2026-04-20 13:00 · Yahoo
How The LENSAR (LNSR) Story Is Shifting After The Failed Alcon Deal And Target Reset
2026-04-05 00:18 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.